Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy
Post term pregnancy is a risk pregnancy. Aim of the study was to investigate whether induction of labor at gestational age 289(41 weeks+2 days) reduces neonatal morbidity compared to expectant management. Secondary aims was to assess the effect on mode of delivery and maternal complications, as well as assess women’s views and experiences.
Our 0-hypothesis was that induction of labor at gestational age 41+2 did not result in better outcome of pregnancy, measured as perinatal morbidity.
Description
Following inclusion, women were randomly allocated to induction of labor or to monitoring of pregnancy every third day until delivery.
Status: Completed (N/A). Started on September 1st, 2002. Ended on July 1st, 2004.
Enrollment: 352 subjects
Study Type: Interventional
Study Design:
- Prevention
- Randomized
- Open Label
- Active Control
- Parallel Assignment
- Safety Study
Conditions:
Interventions:
- Drug: Induction:Misoprostol, Dinoprostone, amniotomy, Oxytocin
Eligibility
Inclusion Criteria:
Routine ultrasound scan and delivery at St.Olav’s Hospital
Ability to speak Norwegian
Singleton pregnancy
Gestational age 289 +/- 2 days
Cephalic presentation
No prelabor rupture of membranes
- Gender
Female
- Mininum Age
N/A
- Maximum Age
N/A
Resources
Source: St. Olavs Hospital
Authority: Norway: Norwegian Social Science Data Services
Locations
-
Department of Obstetrics, St.Olavs Hospital, Trondheim University Hospital
Trondheim
7006
Norway
Officials
Runa Heimstad, MD (Study Director, Unaffiliated)
Sponsors
St. Olavs Hospital (Lead Sponsor)
Norwegian University of Science and Technology (Collaborator)
References
None.
Links
None.
- Date Verified
- October 1st, 2006
- First Received
- October 6th, 2006
- Last Changed
- October 6th, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.